Avadel Pharmaceuticals plc Profit Margin

Avadel Pharmaceuticals plc (AVDL) currently reports a profit margin of -0.11% as of September 2025. That compares with -52.53% in the prior-year period — up 99.8% year over year. That is below the Healthcare sector average of 15.58%. Use the charts on this page to explore Avadel Pharmaceuticals plc's profit margin history and peer comparisons.

Avadel Pharmaceuticals plc's profit margin increased from -52.53% to -0.11% — a 99.8% year-over-year increase (period ending September 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Avadel Pharmaceuticals plc's profit margin of -0.11% is lower than the Healthcare sector average of 15.58%. That is roughly 100.7% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but Avadel Pharmaceuticals plc's current -0.11% should be judged against Healthcare norms (sector average: 15.58%) and against AVDL's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of -0.11%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 15.58%. From there, open related valuation or income-statement pages for Avadel Pharmaceuticals plc, and consider following AVDL for alerts when major investors trade the stock.